Tirzepatide Powers 'Unprecedented' Weight Loss in SURMOUNT-1
The twincretin tirzepatide produced jaw-dropping levels of weight loss in people with obesity and no diabetes compared with placebo in the SURMOUNT-1 pivotal trial with more than 2500 participants.
Medscape Medical News
source https://www.medscape.com/viewarticle/975061?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/975061?src=rss
Comments
Post a Comment